Condition
Malignant Peripheral Nerve Sheath Tumors clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Malignant Peripheral Nerve Sheath Tumors clinical trials that are recruiting, at sites in 6 countries (most in United States (5), Canada (1), India (1)). By phase: Phase 2 (2), Phase 1 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 6Countries
Newest Malignant Peripheral Nerve Sheath Tumors clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Safety and preliminary activity of BMS-986504 in unresectable MPNST | Phase 1/2 | Cleveland, Ohio | Recruiting | Apr 23, 2026 |
| MASCT-I plus doxorubicin and ifosfamide as first-line treatment for advanced soft tissue sarcoma | Phase 2 | Guangzhou | Recruiting | Feb 26, 2024 |
| Testing selinexor for treating Wilms tumors and other solid tumors | Phase 2 | Los Angeles, California and 15 other locations | Recruiting | Aug 14, 2023 |
| Testing MRTX1719 for solid tumors with MTAP deletion | Phase 1 | Phoenix, Arizona and 24 other locations | Recruiting | Feb 18, 2022 |
| B7-H3 CAR T-cell therapy for pediatric solid tumors | Phase 1 | Memphis, Tennessee | Recruiting | May 21, 2021 |
| Registry for Malignant Peripheral Nerve Sheath Tumors | — | Tampa, Florida and 12 other locations | Recruiting | May 4, 2017 |
All recruiting trials (6)
-
Safety and preliminary activity of BMS-986504 in unresectable MPNST
A new medicine called BMS-986504 is being tested to see if it is safe and may help people with unresectable malignant peripheral nerve sheath tumors, especially those whose tumors lack MTAP.
-
MASCT-I plus doxorubicin and ifosfamide as first-line treatment for advanced soft tissue sarcoma
This trial will test whether adding MASCT-I to standard chemotherapy (doxorubicin and ifosfamide) helps adults with advanced soft tissue sarcoma respond better or live longer.
-
Testing selinexor for treating Wilms tumors and other solid tumors
This study is testing if selinexor can help children with certain hard-to-treat tumors, like Wilms tumors, feel better and improve their health.
-
Testing MRTX1719 for solid tumors with MTAP deletion
This study is testing a new drug called MRTX1719 to see if it can help people with advanced solid tumors that have a specific gene deletion.
-
B7-H3 CAR T-cell therapy for pediatric solid tumors
This study is testing a new type of immune therapy using specially modified T cells to see if it can help children with tough-to-treat solid tumors.
-
Registry for Malignant Peripheral Nerve Sheath Tumors
This study is creating a global registry to collect information about malignant peripheral nerve sheath tumors in people with neurofibromatosis type 1 to help improve understanding and treatment of these tumors.
Related topics
Quick answers
How many Malignant Peripheral Nerve Sheath Tumors clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (5 trials), Canada (1 trial), India (1 trial), Japan (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.